LINC00930 was first reported in nasopharyngeal carcinoma [17], where it binds the RBBP5 and GCN5 complexes to the PFKFB3 promoter, elevates H3K4 trimethylation and H3K9 acetylation levels, transactivating PFKFB3, thereby promoting glycolytic flux and cell cycle progression. The gene discussed is PFKFB3; the disease is nasopharyngeal carcinoma.